4//SEC Filing
Imprimis Pharmaceuticals, Inc. 4
Accession 0001493152-15-002168
$HROWCIK 0001360214operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:18 PM ET
Size
8.6 KB
Accession
0001493152-15-002168
Insider Transaction Report
Form 4
Miloni Donald Paul
10% Owner
Transactions
- Sale
Common Stock
2015-05-18$8.00/sh−300,000$2,400,000→ 578,576 total - Sale
Common Stock
2015-05-19$8.00/sh−110,000$880,198→ 468,576 total
Holdings
- 25,316(indirect: By Spouse)
Common Stock
- 101,265(indirect: By LLC)
Common Stock
- 151,898(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Imprimis Pharmaceuticals, Inc.
CIK 0001360214
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001360214
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:18 PM ET
- Size
- 8.6 KB